Blood test could replace biopsies to track prostate cancer treatment
NCT ID NCT01961843
Summary
This small, completed pilot study aimed to find a better way to predict how prostate cancer will respond to a standard drug. Researchers tested whether analyzing cancer cells found in the blood (instead of using painful biopsies) could show if the drug was working. Forty men with advanced prostate cancer received the drug and had their blood tested regularly to look for these clues.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.